When can a medication be tested in an outpatient clinical trial setting like Saltzer medical Group?

When a pharmaceutical company has a new medication they would like to test in a clinical trial, a request is submitted by the sponsoring company to the U.S. Food and Drug Administration (FDA). Before the FDA grants permission to conduct a clinical trial, they will verify that the pharmaceutical company has already done extensive laboratory research regarding the new medication. Only then will the FDA allow a newly proposed medication to be tested in humans. All of the trials currently being conducted at Saltzer are later phase trials in which the medication has been heavily studied prior to being studied in the market it is intended to treat.